Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001903669-25-000008
Filing Date
2025-12-15
Accepted
2025-12-15 18:52:04
Documents
1
Period of Report
2025-12-11

Document Format Files

Seq Description Document Type Size
1 form4-12152025_111200.html 4  
1 form4-12152025_111200.xml 4 7630
  Complete submission text file 0001903669-25-000008.txt   9070
Mailing Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080 (415) 655-4168
SPRUCE BIOSCIENCES, INC. (Issuer) CIK: 0001683553 (see all company filings)

EIN.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2001 JUNIPERO SERRA BOULEVARD, SUITE 640 DALY CITY CA 94014
Business Address
Szwarcberg Javier B. (Reporting) CIK: 0001903669 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39594 | Film No.: 251572921